Metabolix, Inc. to Present at ICR 9th Annual XChange
CAMBRIDGE, Mass., Jan 08, 2007 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX) today announced that it will be presenting at the ICR 9th Annual XChange taking place at the St. Regis Monarch Beach Resort in Dana Point, California on January 10 - 11, 2007.
James Barber, the Company's Chief Executive Officer and Tom Auchincloss, Chief Financial Officer, will be presenting on Thursday, January 11, 2007 at 2:45 p.m. (Pacific Time). The presentation will be webcast and can be accessed on the company's website at www.metabolix.com in the Investor Relations section under Webcasts & Presentations tab or by clicking on the following link: www.corporate-ir.net/ireye/conflobby.zhtml?ticker=MBLX&item_id=1445562
About Metabolix
Founded in 1992, Metabolix, Inc. is developing and commercializing environmentally sustainable and totally biodegradable Natural Plastic as a clean alternative to petroleum-based plastics. The Company is taking a systems approach, from gene to end product, to integrate sophisticated biotechnology with current industrial practice to produce plastics, fuels and chemicals from renewable resources. In addition to its microbial fermentation platform for production of Natural Plastic, Metabolix is also developing a proprietary platform technology for co-producing, in non-food plant crops such as switchgrass, Natural Plastic and biomass for biofuels such as ethanol and for chemical products. For more information, please visit www.metabolix.com. (MBLX-G)
Safe Harbor for Forward-Looking Statements
Comments made during management's presentation may be considered forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements made during the presentation do not constitute guarantees of future performance. Investors are cautioned that statements made during the presentation which are not strictly historical statements, including, without limitation, statements regarding commencement and completion of construction on the commercial manufacturing facility, actual manufacturing capacity of the commercial manufacturing facility, manufacturing plans and performance including the timing of commencement of commercial production of Natural Plastic, commercial viability of Natural Plastic, current or future financial performance and position, management's strategy, plans and objectives for future operations, product development, present and future research and development, regulatory approval and intellectual property, constitute forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated, including, without limitation, risks associated with: our dependence on our collaborative partner for construction of the commercial manufacturing facility, ADM's ability to complete construction of the commercial manufacturing facility on time and on budget, the ability of Metabolix and ADM to successfully manufacture Natural Plastic at commercial scale and in a timely and economic manner, the success of collaborative arrangement with ADM, the market acceptance of our products, our ability to compete with petrochemical-based plastics, fuels and chemicals, our ability to generate future revenues, our expectation of incurring continued losses, the success of our research and development programs, our ability to develop and successfully commercialize Natural Plastic, our ability to obtain required regulatory approvals, our ability to obtain, maintain and protect intellectual property rights for our products, our limited sales and manufacturing capabilities, our ability to hire and retain skilled personnel, and other risks detailed in Metabolix' filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q which was filed on December 13, 2006. Metabolix assumes no obligation to update any forward-looking information made during the presentation or with respect to the announcements described herein.
SOURCE: Metabolix, Inc.
Metabolix, Inc. 21 Erie Street Cambridge, MA 02139 617-492-0505 www.metabolix.com or Investor Relations: Integrated Corporate Relations Kathleen Heaney, 203-803-3585 ir@metabolix.com
Copyright Business Wire 2007
News Provided by COMTEX
